COVID-19 - Explore our insights and resources here.
mobile icon

New Regulatory Waivers Issued by Administration and CMS

New Regulatory Waivers Issued by Administration and CMS

Today, the Centers for Medicare & Medicaid Services issued another round of sweeping regulatory waivers and rule changes to deliver expanded care to the nation’s seniors and provide flexibility to the healthcare system as America reopens. These changes include making it easier for Medicare and Medicaid beneficiaries to get tested for COVID-19 and continuing CMS’s efforts to further expand beneficiaries’ access to telehealth services.

Medicare will no longer require an order from the treating physician or other practitioner for beneficiaries to get COVID-19 tests and certain laboratory tests required as part of a COVID-19 diagnosis. According to CMS, during the Public Health Emergency, COVID-19 tests may be covered when ordered by any healthcare professional authorized to do so under state law. To help ensure that Medicare beneficiaries have broad access to testing related to COVID-19, a written practitioner’s order is no longer required for the COVID-19 test for Medicare payment purposes.

Although there is no direct guidance at this time for Ambulatory Surgery Centers, CMS announced it will pay hospitals and practitioners to assess beneficiaries and collect laboratory samples for COVID-19 testing, and make separate payment when that is the only service the patient receives. This builds on previous action to pay laboratories for technicians to collect samples for COVID-19 testing from homebound beneficiaries and those in certain non-hospital settings, and encourages broader testing by hospitals and physician practices. To help facilitate expanded testing and reopen the country, CMS is announcing that Medicare and Medicaid are covering certain serology (antibody) tests, which may aid in determining whether a person may have developed an immune response and may not be at immediate risk for COVID-19 reinfection. Medicare and Medicaid will cover laboratory processing of certain FDA-authorized tests that beneficiaries self-collect at home.

Other waiver announcements include:

  • Healthcare Workforce Augmentation
  • Put Patients Over Paperwork/Decrease Administrative Burden
  • Further Expand Telehealth in Medicare

On a public call hosted by CMS for Ambulatory Surgery Centers, the agency indicated it will review inquiries related to Covid-19 testing needs of ASCs and any applicable billing and reimbursement considerations; confirming that at this time, ASCs are not approved for this testing.

Read More: https://www.cms.gov/newsroom/press-releases/trump-administration-issues-second-round-sweeping-changes-support-us-healthcare-system-during-covid

 


This post was first published April 30, 2020 and was updated July 29, 2020.

SUBSCRIBE TO NATIONAL MEDICAL UPDATES

OUR AWARDS